Effects of apple juice on risk factors of lipid profile, inflammation and coagulation, endothelial markers and atherosclerotic lesions in high cholesterolemic rabbits.
BACKGROUND
Atherosclerosis which results from gradual deposition of lipids in medium and large arteries is a leading cause of mortality worldwide. The objective of this study was to determine the effect of apple juice on some risk factors of atherosclerosis and on the development of atherosclerosis in rabbits fed a high-cholesterol diet.


METHODS
Thirty two male rabbits were randomly divided into four groups: normal diet, high cholesterol diet (%1 cholesterol), 1% cholesterol supplemented with 5 ml apple juice (low dose) and 1% cholesterol supplemented with 10 ml apple juice (high dose) for 2 month. The C-reactive protein (CRP), nitrite, nitrate, fibrinogen, total cholesterol(TC) and factor VII were measured before the experiment and by the end of period. At the end of study, fatty streak formation in right and left coronary arteries were determined using Chekanov method in all groups.


RESULTS
Both doses of apple juice significantly were decreased TC, TG, CRP, fibrinogen, factor VII levels, atherosclerotic lesion in right and left coronary arteries and increased nitrite and nitrate compared to cholesterolemic diet. Also using 10 ml apple juice caused significant reduce in LDL-C and increase HDL-C, but 5 ml apple juice did not change these factors. Significant differences were observed between 5 and 10 ml apple juice groups by LDL-C. No significant difference was found between 5 and 10 ml apple juice groups with regard to CRP, nitrite, nitrate, fibrinogen, factor VII, TG, HDL-C and TC concentrations.


CONCLUSIONS
Apple juice can effectively prevent the progress of atherosclerosis. This is likely due to antioxidant and anti-inflammatory effect of apple juice.
Setorki
Mahbubeh
M
Department of Biology, Science and Research Branch, Islamic Azad University, Tehran, Iran. doctor.setorgi@yahoo.com
Asgary
Sedighe
S
Eidi
Akram
A
Rohani
Ali Haeri
AH
Esmaeil
Nafiseh
N
D000818:Animals; D050197:Atherosclerosis / Q000178:diet therapy / Q000378:metabolism* / Q000517:prevention & control; D001628:Beverages; D002097:C-Reactive Protein / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D005340:Fibrinogen / Q000378:metabolism; D007249:Inflammation / Q000178:diet therapy / Q000378:metabolism* / Q000517:prevention & control; D050356:Lipid Metabolism; D008297:Male; D027845:Malus; D009566:Nitrates / Q000378:metabolism; D009573:Nitrites / Q000378:metabolism; D011817:Rabbits; D011897:Random Allocation
D009566:Nitrates; D009573:Nitrites; D005340:Fibrinogen; D002097:C-Reactive Protein; D002784:Cholesterol